This research is all aimed at tissue repair strategies, but it also may provide new in
vitro models for human disease.
Not exact matches
NYSCF partners with a broad range of institutions, foundations, centers and companies in a variety of ways ranging from the creation of fundamental research resources such as iPSC lines
for a
disease area to developing
human disease models in
vitro to enable drug discovery and toxicity testing.
Our in
vitro study provides a baseline
for defining healthy and
disease - like states and highlights the power of moving beyond single and dual species applications to capture key players and their orchestrated metabolic activities within a complex
human oral microbiome
model.
We are developing in vivo
models for the
disease in the mouse, and in
vitro models starting from
human pluripotent stem cell lines.
Reprogramming
human somatic cells to pluripotency represents a valuable resource
for the development of in
vitro based
models for human disease and holds tremendous potential
for deriving patient - specific pluripotent stem cells.
These findings have identified an alternative source of replacement tissue
for use in
human retinal cellular therapies, and provide a new in
vitro cellular
model system in which to study RPE
diseases affecting
human patients.
Taken together, these results demonstrated that
disease - specific
human iPS cell — derived hepatocytes are capable of
modeling key pathological feature of A1ATD in
vitro and may also prove useful
for future drug screening assays.